SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002948
Filing Date
2021-11-04
Accepted
2021-11-04 09:21:33
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20210930.htm   iXBRL 10-Q 2873811
2 EX-10.1 igms-ex10_1.htm EX-10.1 60406
3 EX-31.1 igms-ex31_1.htm EX-31.1 17852
4 EX-31.2 igms-ex31_2.htm EX-31.2 16340
5 EX-32.1 igms-ex32_1.htm EX-32.1 10552
6 EX-32.2 igms-ex32_2.htm EX-32.2 10547
  Complete submission text file 0000950170-21-002948.txt   8872131

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20210930_cal.xml EX-101.CAL 47827
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20210930_pre.xml EX-101.PRE 313273
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20210930_lab.xml EX-101.LAB 420452
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20210930.xsd EX-101.SCH 54040
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20210930_def.xml EX-101.DEF 203957
12 EXTRACTED XBRL INSTANCE DOCUMENT igms-20210930_htm.xml XML 1575129
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 211378486
SIC: 2834 Pharmaceutical Preparations